Grifols Deutschland GmbH, a subsidiary of the global biopharmaceutical company Grifols, is headquartered in Germany and operates extensively across Europe. Founded in 1909, Grifols has established itself as a leader in the healthcare industry, particularly in the fields of plasma-derived medicines, hospital pharmacy, and diagnostic solutions. The company is renowned for its innovative products, including immunoglobulins, albumin, and clotting factors, which are vital for treating various medical conditions. Grifols' commitment to quality and patient care has positioned it as a trusted name in the biopharmaceutical sector. With a strong market presence and a focus on research and development, Grifols Deutschland GmbH continues to make significant contributions to healthcare, enhancing the lives of patients worldwide.
How does Grifols Deutschland GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Grifols Deutschland GmbH's score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Grifols Deutschland GmbH currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Grifols, S.A., and any emissions data or climate commitments would be inherited from this parent organisation. As of now, Grifols, S.A. has not publicly disclosed specific reduction targets or initiatives for Grifols Deutschland GmbH. The company is involved in broader climate initiatives, including those reported through the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are cascaded down from Grifols, S.A. However, no specific targets or commitments have been outlined for Grifols Deutschland GmbH at this time. In the absence of detailed emissions data and reduction targets, it is important to note that Grifols, S.A. is committed to sustainability and reducing its overall carbon footprint, which may influence the operations of its subsidiaries, including Grifols Deutschland GmbH.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 85,532,000 | 00,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 113,055,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 64,761,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
Grifols Deutschland GmbH's Scope 3 emissions, which increased by 11% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 53% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Grifols Deutschland GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.